Your session is about to expire
← Back to Search
Sustained Release Dexamethasone, 0.4 mg for Dry Eye Syndrome
Study Summary
This trial is testing whether or not a dexamethasone 0.4mg lacrimal insert is effective and safe in treating dry eye related ocular surface inflammation.
- Dry Eye Syndrome
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
To what extent is the participation rate in this research project?
"Absolutely, the information posted on clinicaltrials.gov indicates that this examination is actively enrolling participants. This research project was initially advertised on March 16th 2021 and has been modified most recently in January 24th 2022. It needs 85 volunteers to be recruited at one medical centre."
What health issues does Sustained Release Dexamethasone, 0.4 mg typically address?
"Sustained Release Dexamethasone, 0.4 mg has been given to patients for the treatment of ophthalmia and sympathetic conditions such as branch retinal vein occlusion, macular edema, and various other eye issues."
Are there any prior investigations of Sustained Release Dexamethasone, 0.4 mg?
"Presently, 553 medical studies are assessing the efficacy of Sustained Release Dexamethasone, 0.4 mg with 144 trials in Phase 3. While a majority of these clinical tests take place in Mishawaka, Indiana , there are 18,618 sites globally running similar experiments for this drug."
Has the Administration granted authorization to Sustained Release Dexamethasone, 0.4 mg?
"The safety rating for Sustained Release Dexamethasone, 0.4 mg is 3 on a scale of 1-3 due to it being in the final phase (Phase 4) and having been approved by regulatory agencies."
Does this research initiative have any upper age restrictions?
"This clinical trial is including individuals who are of legal age and younger than a century."
Is this research program still open for enrollment?
"Clinicaltrials.gov confirms that this medical experiment is open for recruitment, having been first published on March 16th 2021 and last edited on January 24th 2022."
Does my profile meet the criteria for enrollment in this research?
"Participants need to meet two criteria in order to be accepted into this research: they must suffer from dry eyes, and be between 18 and 100 years of age. Currently 85 candidates are being enrolled for the trial."
Who else is applying?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger